XML 54 R41.htm IDEA: XBRL DOCUMENT
v3.24.3

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Segment Reporting [Abstract] |
Schedule of Business Segments |
| Engineered Materials |  |  |  | Acetyl Chain |  | Other Activities |  | Eliminations |  | Consolidated |
| (In $ millions) |
| Three Months Ended September 30, 2024 |
Net sales | 1,481 |  |  |  |  | 1,190 |  |  | — |  |  | (23) |  | (1) | 2,648 |  |
Other (charges) gains, net (Note 18) | (60) |  |  |  |  | 1 |  |  | (2) |  |  | — |  |  | (61) |  |
Operating profit (loss) | 102 |  |  |  |  | 239 |  |  | (93) |  |  | — |  |  | 248 |  |
Equity in net earnings (loss) of affiliates | 44 |  |  |  |  | 2 |  |  | 5 |  |  | — |  |  | 51 |  |
Depreciation and amortization | 127 |  |  |  |  | 63 |  |  | 13 |  |  | — |  |  | 203 |  |
Capital expenditures | 59 |  |  |  |  | 33 |  |  | 7 |  |  | — |  |  | 99 |  | (2)
| Three Months Ended September 30, 2023 |
Net sales | 1,528 |  |  |  |  | 1,220 |  |  | — |  |  | (25) |  | (1) | 2,723 |  |
Other (charges) gains, net (Note 18) | (15) |  |  |  |  | — |  |  | (2) |  |  | — |  |  | (17) |  |
Operating profit (loss) | 691 |  |  |  | (3) | 272 |  |  | (121) |  |  | — |  |  | 842 |  |
Equity in net earnings (loss) of affiliates | 8 |  |  |  |  | 1 |  |  | 3 |  |  | — |  |  | 12 |  |
Depreciation and amortization | 111 |  |  |  |  | 55 |  |  | 7 |  |  | — |  |  | 173 |  |
Capital expenditures | 51 |  |  |  |  | 44 |  |  | 24 |  |  | — |  |  | 119 |  | (2)
______________________________ (1)Includes intersegment sales primarily related to the Acetyl Chain. (2)Includes an increase in accrued capital expenditures of $11 million and a decrease of $12 million for the three months ended September 30, 2024 and 2023, respectively. (3)Includes a gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the unaudited interim consolidated statements of operations (Note 3).
| Engineered Materials |  |  |  | Acetyl Chain |  | Other Activities |  | Eliminations |  | Consolidated |
| (In $ millions) |
| Nine Months Ended September 30, 2024 |
Net sales | 4,326 |  |  |  |  | 3,653 |  |  | — |  |  | (69) |  | (1) | 7,910 |  |
Other (charges) gains, net (Note 18) | (114) |  |  |  |  | — |  |  | (9) |  |  | — |  |  | (123) |  |
Operating profit (loss) | 329 |  |  |  |  | 735 |  |  | (356) |  |  | — |  |  | 708 |  |
Equity in net earnings (loss) of affiliates | 140 |  |  |  |  | 7 |  |  | 10 |  |  | — |  |  | 157 |  |
Depreciation and amortization | 395 |  |  |  |  | 181 |  |  | 40 |  |  | — |  |  | 616 |  |
Capital expenditures | 137 |  |  |  |  | 109 |  |  | 45 |  |  | — |  |  | 291 |  | (2)
| As of September 30, 2024 |
Goodwill and intangible assets, net | 10,426 |  |  |  |  | 429 |  |  | — |  |  | — |  |  | 10,855 |  |
Total assets | 17,631 |  |  |  |  | 5,544 |  |  | 2,717 |  |  | — |  |  | 25,892 |  |
| Nine Months Ended September 30, 2023 |
Net sales | 4,743 |  |  |  |  | 3,703 |  |  | — |  |  | (75) |  | (1) | 8,371 |  |
Other (charges) gains, net (Note 18) | (44) |  |  |  |  | (1) |  |  | (5) |  |  | — |  |  | (50) |  |
Operating profit (loss) | 961 |  |  |  | (3) | 845 |  |  | (378) |  |  | — |  |  | 1,428 |  |
Equity in net earnings (loss) of affiliates | 37 |  |  |  |  | 4 |  |  | 9 |  |  | — |  |  | 50 |  |
Depreciation and amortization | 335 |  |  |  |  | 163 |  |  | 19 |  |  | — |  |  | 517 |  |
Capital expenditures | 154 |  |  |  |  | 162 |  |  | 63 |  |  | — |  |  | 379 |  | (2)
| As of December 31, 2023 |
Goodwill and intangible assets, net | 10,525 |  |  |  |  | 427 |  |  | — |  |  | — |  |  | 10,952 |  |
Total assets | 17,930 |  |  |  |  | 5,538 |  |  | 3,129 |  |  | — |  |  | 26,597 |  |
______________________________ (1)Includes intersegment sales primarily related to the Acetyl Chain. (2)Includes a decrease in accrued capital expenditures of $39 million and $61 million for the nine months ended September 30, 2024 and 2023, respectively. (3)Includes a gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the unaudited interim consolidated statements of operations (Note 3).

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration